Tabernaemontana divaricata — Hermetica Encyclopedia
Herb · Southeast Asian

Tabernaemontana divaricata

Preliminary EvidenceCompound

Hermetica Superfood Encyclopedia

The Short Answer

Tabernaemontana divaricata contains a complex profile of indole alkaloids — including coronaridine, voacangine, ibogamine, and conophylline — that disrupt bacterial membranes, inhibit glycolytic enzymes, and exert cytotoxic activity against cancer cell lines via incompletely characterized pathways. Preclinical in vitro studies report IC50 values of 0.17–1.49 µM for conophylline against HL-60, MCF-7, and A-549 cancer cell lines, and antibacterial IC50 values as low as 6.71 µg/mL for ethyl acetate fractions, though no human clinical trials have been conducted to validate these findings.

PubMed Studies
7
Validated Benefits
Synergy Pairings
At a Glance
CategoryHerb
GroupSoutheast Asian
Evidence LevelPreliminary
Primary KeywordTabernaemontana divaricata benefits
Tabernaemontana divaricata close-up macro showing natural texture and detail — rich in antimicrobial, antioxidant, digestive
Tabernaemontana divaricata — botanical close-up

Health Benefits

**Antimicrobial Activity**: Ethyl acetate and n-butanol fractions of T
divaricata flower extracts inhibit bacterial growth with IC50 values of 6.71±0.19 µg/mL and 26.15±0.08 µg/mL respectively, attributed to membrane-disrupting indole alkaloids like coronaridine and voacangine acting on bacterial cell wall integrity.
**Antioxidant Protection**
Methanolic extracts demonstrate DPPH free radical scavenging activity (15.9±2.33%) alongside catalase activity (65.57±13.4%) and superoxide dismutase (SOD 3.02±3.4 units), driven by a total phenolic content of 62.32±4.02 mg/g and total flavonoid content of 24.53±0.61 mg/g that quench reactive oxygen species.
**Antidiabetic Potential**
Plant extracts inhibit the digestive enzymes α-amylase and α-glucosidase in vitro, mechanisms that delay postprandial glucose absorption analogous to pharmaceutical alpha-glucosidase inhibitors, though effective concentrations in humans remain unestablished.
**Cytotoxic and Anticancer Properties**: The alkaloid conophylline exhibits cytotoxic activity against multiple cancer cell lines
HL-60, SMMC-7721, A-549, MCF-7, and SW480 — with IC50 values of 0.17–1.49 µM in cell-based assays, suggesting potential antiproliferative mechanisms that remain under investigation.
**Anti-inflammatory Effects**
Traditional use of leaf and bark preparations for inflammatory conditions is supported by the presence of flavonoids and tannins known to inhibit pro-inflammatory mediators, although specific cyclooxygenase (COX) or NF-κB pathway data for this species are not yet published.
**Traditional Ocular Applications**
In Filipino hilot (traditional healing), juice from the plant is applied topically to the eyes for ailments such as conjunctivitis and inflammation, a practice rooted in the plant's presumed antimicrobial and anti-inflammatory alkaloid content, though clinical ophthalmological evidence is absent.
**Hemolytically Low Cytotoxicity**
In vitro red blood cell hemolysis assays demonstrate only 10% hemolysis at tested extract concentrations, suggesting a preliminary tolerability margin for future safety assessment, though this does not substitute for systemic in vivo or clinical toxicology data.

Origin & History

Tabernaemontana divaricata growing in India — natural habitat
Natural habitat

Tabernaemontana divaricata is native to South and Southeast Asia, with its range spanning India, Sri Lanka, Thailand, Vietnam, and the Philippines, where it grows in tropical lowland forests, roadsides, and cultivated gardens at low to moderate elevations. It thrives in humid, warm climates with well-drained soils and is widely cultivated as an ornamental shrub across tropical regions due to its distinctive pinwheel-shaped white flowers. In the Philippines, it is integrated into traditional horticultural and medicinal practice, where different plant parts — leaves, bark, flowers, stems, and roots — are harvested for therapeutic preparations.

Tabernaemontana divaricata has a centuries-long history of medicinal use across South and Southeast Asian traditional medicine systems, including Ayurveda (where it is known as 'Nandivriksha' or 'Tagara'), Thai traditional medicine, and Filipino hilot, where healers apply flower or leaf extracts directly to the eyes to treat conjunctivitis, eye inflammation, and visual disturbances. In Ayurvedic texts, the plant's bark and root were prescribed for conditions including fever, skin diseases, and rheumatism, reflecting a broad polyvalent therapeutic profile typical of iboga-alkaloid-bearing plants across the Apocynaceae family. The presence of ibogamine-related alkaloids structurally analogous to ibogaine — a compound derived from the related African species Tabernanthe iboga — lends particular pharmacological interest to this plant, drawing parallels to traditional African ceremonial and medicinal uses of iboga-alkaloid plants. In the Philippines, T. divaricata is one of several medicinal plants incorporated into hilot healing rituals, where the practitioner's application of plant juices to sensory organs reflects a holistic diagnostic and therapeutic paradigm rooted in pre-colonial botanical knowledge.Traditional Medicine

Scientific Research

The entirety of published evidence for T. divaricata derives from in vitro cell-based assays and phytochemical characterization studies; no human clinical trials, animal dose-response models with clinical endpoints, or Phase I pharmacokinetic studies have been reported in indexed literature. Antibacterial studies have used zone-of-inhibition and MIC/IC50 assays at extract volumes of 25–100 µL, cytotoxicity has been assessed against five cancer cell lines using standard MTT assays (IC50 0.17–1.49 µM for conophylline), and antioxidant capacity has been measured through DPPH, FRAP, and enzymatic activity assays. Novel alkaloids including taberdivamines A and B, tabernaricatines F and G, and 5-oxocoronaridine have been structurally characterized by NMR and mass spectrometry, advancing chemodiversity knowledge but not therapeutic validation. The evidence base is best classified as exploratory phytochemistry and preliminary bioactivity screening, with significant translational gaps before any clinical recommendations can be responsibly made.

Preparation & Dosage

Tabernaemontana divaricata ground into fine powder — pairs with No formally studied synergistic combinations involving T. divaricata extracts or its isolated alkaloids have been reported in indexed literature. Theoretically, the plant's flavonoid and phenolic antioxidant constituents may exhibit additive or synergistic antioxidant activity when combined with other polyphenol-rich botanical extracts such as green tea (Camellia sinensis) catechins or turmeric (Curcuma longa)
Traditional preparation
**Traditional Aqueous Infusion (Leaves/Flowers)**
Fresh or shade-dried plant material steeped in water; used topically for eye conditions in Filipino hilot; no standardized volume or concentration established for safe human use.
**Crude Ethanol/Methanol Extract (Research Grade)**
25 g) extracted via maceration with 70–95% ethanol or methanol; used at 40–100 mg/mL concentrations in antibacterial and antioxidant assays; not validated for human supplemental dosing
Shade-dried powdered material (.
**Aqueous Extract (Antibacterial Screening)**
Tested at 25–100 µL volumes in disc-diffusion and microbroth dilution assays; effective IC50 of 6.71 µg/mL (ethyl acetate fraction) is a laboratory metric, not a human dose.
**Solvent Fractions (Phytochemical Isolation)**
Sequential fractionation using hexane, chloroform, ethyl acetate, and n-butanol yields alkaloid-enriched fractions used in cytotoxicity and enzyme inhibition studies; no bioavailability data available.
**Standardization**
10–12 mg/g (aqueous) and flavonoids 9–16 mg/g (ethanol), but no standardization benchmarks have been clinically validated
No commercial standardized extract exists; alkaloid content in flowers measures approximately .
**Important Note**
No safe or effective human supplemental dose has been established for any preparation; all dosage figures in the literature are in vitro research parameters only.

Nutritional Profile

Tabernaemontana divaricata is not consumed as a food and does not contribute meaningfully to macronutrient nutrition; however, methanolic flower extracts contain protein at approximately 22.82±4.6 mg/g dry weight, representing a minor protein fraction of likely structural and enzymatic plant proteins. The dominant phytochemical constituents are indole alkaloids (10–12 mg/g in aqueous flower extracts), total phenolics (62.32±4.02 mg/g in methanolic extracts), and total flavonoids (24.53±0.61 mg/g methanolic; 16.2±0.48 mg/g ethanolic), alongside tannins, terpenoids, and steroids detected qualitatively across plant parts. Specific flavonoid identities and their bioavailability in humans have not been characterized for this species; the presence of tannins may reduce absorption of co-ingested minerals and proteins via polyphenol-protein complexation. No meaningful data exist on caloric density, carbohydrate, lipid, vitamin, or mineral content relevant to human nutrition.

How It Works

Mechanism of Action

The primary bioactive alkaloids of T. divaricata — coronaridine, ibogamine, voacangine, and conophylline — belong to the iboga-type and vobasine-type indole alkaloid classes, which interact with bacterial membranes through amphiphilic structural features that disrupt lipid bilayer integrity, leading to membrane permeabilization and cell death. Antioxidant activity is mediated by the hydroxyl-rich polyphenolic and flavonoid constituents, which donate hydrogen atoms to neutralize DPPH and superoxide radicals, while simultaneously modulating enzymatic antioxidant defenses including catalase and peroxidase activity. Antidiabetic effects are attributed to competitive or mixed inhibition of α-amylase and α-glucosidase, reducing the hydrolysis of dietary polysaccharides and thereby blunting postprandial glycemic excursions, though the specific binding residues and kinetic parameters remain uncharacterized. Cytotoxic alkaloids such as conophylline exert antiproliferative effects on cancer cell lines via unspecified intracellular pathways — potentially involving DNA intercalation, mitochondrial membrane disruption, or caspase activation — a mechanistic gap that represents a priority for future molecular pharmacology research.

Clinical Evidence

No clinical trials involving T. divaricata extract, its alkaloid fractions, or isolated compounds have been conducted in human subjects as reported in currently available literature. Consequently, there are no published data on clinical outcomes, therapeutic effect sizes, optimal dosing windows, or adverse event profiles in patient populations. The plant's therapeutic relevance to human health rests entirely on traditional ethnobotanical use — particularly in Filipino hilot for ocular and inflammatory conditions — and on in vitro bioactivity data that, while promising, cannot be extrapolated to clinical efficacy without controlled human trials. Confidence in any therapeutic application is very low by evidence-based medicine standards, and use in clinical or supplemental contexts should be approached with significant caution.

Safety & Interactions

Human safety data for T. divaricata are absent from the published literature; the only available tolerability metric is 10% hemolysis of human red blood cells at in vitro assay concentrations, which provides minimal translational insight into systemic toxicity at relevant human doses. The structural resemblance of T. divaricata alkaloids (coronaridine, ibogamine) to ibogaine — a compound associated with QTc prolongation, hallucinations, seizures, and fatalities at high doses in humans — raises significant theoretical safety concerns that have not been formally evaluated in toxicological studies specific to this species. Potential drug interactions are unstudied but pharmacologically plausible: iboga-type alkaloids may interfere with serotonergic, dopaminergic, and adrenergic neurotransmitter systems, potentially interacting with antidepressants (SSRIs, MAOIs), antiarrhythmics, and CNS-active medications. Pregnancy, lactation, pediatric use, and use in individuals with hepatic or cardiac conditions should be considered absolute contraindications until safety data are generated, given the cytotoxic alkaloid profile and absence of reproductive toxicology studies.

Synergy Stack

Hermetica Formulation Heuristic

Also Known As

Tabernaemontana divaricata (L.) R.Br. ex Roem. & Schult.Pinwheel FlowerCrape JasmineNandivrikshaTagaraErvatamia divaricataChandniNero's CrownEast India Rosebay

Frequently Asked Questions

What is Tabernaemontana divaricata used for in traditional medicine?
In Filipino hilot, plant juice from T. divaricata is applied topically to the eyes to treat conjunctivitis and inflammation, while in Ayurvedic medicine, bark and root preparations have historically been used for fever, skin disease, and rheumatism. Across South and Southeast Asia, leaves, bark, flowers, stems, and roots are used in preparations targeting infections, inflammation, diabetes management, and as topical antimicrobials, though none of these uses have been validated in human clinical trials.
Does Tabernaemontana divaricata contain ibogaine?
Tabernaemontana divaricata does not contain ibogaine itself, but it does contain structurally related iboga-type indole alkaloids including ibogamine, coronaridine, and voacangine, which share the ibogamine skeleton with ibogaine from the African species Tabernanthe iboga. These alkaloids carry theoretical pharmacological and safety implications similar to ibogaine — including potential cardiovascular and neurological effects — though specific human pharmacology studies for T. divaricata alkaloids have not been conducted.
Are there any clinical trials on Tabernaemontana divaricata for humans?
No human clinical trials for Tabernaemontana divaricata have been published in the indexed scientific literature; all bioactivity data derive from in vitro cell-based assays, disc-diffusion antibacterial tests, and enzyme inhibition studies using crude extracts or isolated compounds. Without clinical trial data, no evidence-based therapeutic dose, efficacy claim, or safety profile can be established for any human condition.
What alkaloids are found in Tabernaemontana divaricata and what do they do?
Key indole alkaloids identified in T. divaricata include coronaridine, voacangine, ibogamine, voacristine, 16-epi-affinine, conophylline, 5-oxocoronaridine, taberdivamines A and B, and tabernaricatines F and G. In vitro studies show conophylline has cytotoxic activity (IC50 0.17–1.49 µM) against cancer cell lines including MCF-7 and A-549, while coronaridine and voacangine contribute to antibacterial membrane disruption, and the alkaloid fraction collectively inhibits α-amylase and α-glucosidase enzymes relevant to blood sugar regulation.
Is Tabernaemontana divaricata safe to use as a supplement or herbal remedy?
The safety of T. divaricata for human use has not been formally evaluated; in vitro hemolysis assays show only 10% red blood cell lysis at tested concentrations, but this does not reflect systemic human safety. The plant's iboga-type alkaloids are structurally analogous to ibogaine, a compound associated with serious cardiovascular and neurological risks in humans, making self-administration as a supplement inadvisable until rigorous toxicological and clinical pharmacokinetic studies are completed.
What is the difference between Tabernaemontana divaricata flower extract and leaf extract?
Flower extracts of Tabernaemontana divaricata demonstrate superior antimicrobial potency compared to other plant parts, with ethyl acetate fractions showing IC50 values as low as 6.71±0.19 µg/mL against bacterial pathogens. The flower's concentrated alkaloid profile, particularly indole alkaloids like coronaridine and voacangine, makes it the most researched and bioactive form for antimicrobial and antioxidant applications. Leaf extracts may contain different alkaloid ratios and lower antimicrobial activity, making flower-derived supplements more standardized for therapeutic purposes.
How do the alkaloids in Tabernaemontana divaricata work against bacteria?
The indole alkaloids found in Tabernaemontana divaricata, such as coronaridine and voacangine, disrupt bacterial cell wall integrity and compromise membrane function, leading to bacterial growth inhibition. These alkaloids target the structural components essential for bacterial cell survival, making them effective against multiple bacterial strains in laboratory studies. The membrane-disrupting mechanism explains why ethyl acetate and n-butanol fractions show potent antimicrobial activity with low IC50 values.
Who should consider Tabernaemontana divaricata supplementation for its antimicrobial or antioxidant benefits?
Individuals seeking natural antimicrobial support or those interested in antioxidant protection may benefit from Tabernaemontana divaricata, though human clinical evidence remains limited. People with recurrent bacterial infections or those looking for botanical alternatives to conventional antimicrobial agents are potential candidates, provided they consult healthcare providers first. However, due to its ibogaine-related alkaloid content and lack of extensive human safety data, it is not recommended for pregnant women, children, or those taking medications that may interact with its alkaloid compounds.

Explore the Full Encyclopedia

7,400+ ingredients researched, verified, and formulated for optimal synergy.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.